2 completed, 1 terminated. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Completed 2, Terminated 1 |
Follow Malaria, Vivax: new trials by email Literature Review of Malaria, Vivax trials Research Report on Malaria, Vivax
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of Pvs25-IMX313/Matrix-M1 Vaccine Pvs25-IMX313/Matrix-M1 - Malaria, Vivax | Early Phase 1 | Terminated | University of Oxford | 25 | 2022-02-09 | 2026-01-15 |
| VAC069: A Study of Blood-stage Controlled Human P. Vivax Infection P. vivax infected inoculum (parasitised red blood cells) - Malaria, Vivax | Early Phase 1 | Completed | University of Oxford | 19 | 2019-01-10 | 2025-04-25 |
| Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human Volunteers Sporozoite Challenge Model for Plasmodium vivax in Humans - Malaria, Vivax | Early Phase 1 | Completed | Malaria Vaccine and Drug Development Center | 18 | 2005-01-01 | 2010-03-09 |
Malaria (1)
Infections (3) · Mosquito-Borne Diseases (3) · Parasitic Diseases (3) · Protozoan Infections (3) · Vector Borne Diseases (3) · Malaria (2)
Matrix-M (1)
University of Oxford (2) · Malaria Vaccine and Drug Development Center (1)
United Kingdom (2) · Colombia (1)
Angela M Minassian, DPhil FRCP (1) · Angela M Minassian, MBBS MA DPhil MRCP FRCPath (1) · Socrates Herrera, MD (1)
PMID 11716100, PMID 11741694, PMID 11816444, PMID 12171615, PMID 12476490, PMID 13356045, PMID 14579464, PMID 14582335, PMID 1688828, PMID 2094597, PMID 34609964, PMID 3511753, PMID 35664997, PMID 37616070, PMID 40998768, PMID 4590095, PMID 7475658, PMID 7660433, PMID 7785527, PMID 7845714, PMID 7932927, PMID 808142, PMID 8357078, PMID 8376823, PMID 8842108, PMID 9086149, PMID 9192643, PMID 9797827